Summit Therapeutics Inc/ US86627T1088 /
| 2024-04-26 10:00:00 PM | Chg. +0.3100 | Volume | Bid1:05:10 AM | Ask1:05:10 AM | High | Low |
|---|---|---|---|---|---|---|
| 3.8600USD | +8.73% | 1.39 mill. Turnover: 4.74 mill. |
3.6500Bid Size: 500 | 3.9300Ask Size: 100 | 3.9000 | 3.5200 |
GlobeNewswire
03-25
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
GlobeNewswire
03-07
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...
GlobeNewswire
02-28
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...
GlobeNewswire
02-21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...
GlobeNewswire
02-08
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
GlobeNewswire
2022-03-17
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter an...
GlobeNewswire
2022-02-01
Dr. Maky Zanganeh Launches Personal Memoir, the Magic of Normal, to Honor February Cancer Survivor M...
GlobeNewswire
2022-01-10
Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ...
GlobeNewswire
2022-01-05
Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conferen...
GlobeNewswire
2021-12-20
Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infecti...
GlobeNewswire
2021-11-15
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and...
GlobeNewswire
2021-11-04
Entasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-11-03
Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Exe...
GlobeNewswire
2021-10-11
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...
GlobeNewswire
2021-10-08
Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of...
GlobeNewswire
2021-10-04
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...
GlobeNewswire
2021-09-30
Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action...
GlobeNewswire
2021-09-24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...
GlobeNewswire
2021-08-11
Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-08-11
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Si...
